title: Role of the heparin binding domain of fibronectin in attachment and spreading of human bone-derived cells.
abstract: Human bone-derived cells are known to attach and spread on surfaces which have been precoated with fibronectin, but the contributions made by specific domains of the molecule have not yet been defined. Here we refer to the osteoblast-like cells as human bone cells. We have determined the relevance of separate regions of fibronectin, particularly the heparin-binding region, for the initial attachment and spreading of these cells. Human bone cells attached to fragments from each of the cell- and heparin-binding regions of fibronectin, but failed to attach to a fragment from the gelatin-binding region. Bovine corneal epithelial cells, which were included as an example of an alternative primary cell strain, attached to the cell-binding fragment but showed no specific short-term attachment to the heparin or gelatin-binding fragments. Monoclonal antibody MAb17, which binds to the cell binding region of fibronectin, partially inhibited the attachment of both human bone cells and corneal epithelial cells to intact fibronectin when present at 50 micrograms/ml and reduced human bone cell attachment to the cell-binding region fragment of fibronectin. Monoclonal antibody, MAb 32, which binds to the heparin-binding region of fibronectin, failed to inhibit attachment of the human bone cells to fibronectin but reduced the attachment of these cells to the heparin-binding region fragment. Heparin and chondroitin sulphate were able to inhibit human bone cell attachment to the heparin-binding fragment of fibronectin but had no effect on their attachment to intact fibronectin or the cell-binding region of fibronectin. Immunofluorescent staining and confocal microscopy showed extensive spreading and actin filament formation when human bone cells were cultured on intact fibronectin. Cells cultured on the heparin-binding fragment showed only minimal spreading coinciding with less extensive actin filament organisation. On the cell-binding fragment of fibronectin more spreading was seen than on the heparin-binding fragment but it was not as extensive as on intact fibronectin. Taken together, these data suggest that human bone cells, unlike bovine corneal epithelial cells, have an attachment mechanism for the heparin-binding region of fibronectin. Attachment to this region is probably mediated by cell surface proteoglycans. However, interaction with the cell-binding domain is required for effective cell spreading of human bone cells on fibronectin during the first 90 minutes after seeding into culture.
authors.affiliation: CSIRO Division of Biomolecular Engineering, Sydney Laboratory, North Ryde, NSW, Australia.
authors.forename: B A
authors.initials: BA
authors.lastname: Dalton
authors.forename: C D
authors.initials: CD
authors.lastname: McFarland
authors.forename: P A
authors.initials: PA
authors.lastname: Underwood
authors.forename: J G
authors.initials: JG
authors.lastname: Steele
mesh_terms: D008841:Actin Cytoskeleton / Q000648:ultrastructure; D000199:Actins / Q000378:metabolism; D000595:Amino Acid Sequence; D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D001665:Binding Sites; D001842:Bone and Bones / Q000166:cytology*; D002417:Cattle; D002448:Cell Adhesion; D048429:Cell Size; D002478:Cells, Cultured; D002648:Child; D002809:Chondroitin Sulfates / Q000378:metabolism / Q000494:pharmacology; D003315:Cornea / Q000166:cytology; D004847:Epithelial Cells; D004848:Epithelium / Q000378:metabolism; D005353:Fibronectins / Q000737:chemistry / Q000276:immunology / Q000378:metabolism*; D005780:Gelatin / Q000378:metabolism; D006493:Heparin / Q000378:metabolism* / Q000494:pharmacology; D006801:Humans; D008969:Molecular Sequence Data; D009842:Oligopeptides / Q000378:metabolism; D009928:Organ Specificity; D010006:Osteoblasts / Q000166:cytology / Q000378:metabolism*; D010446:Peptide Fragments / Q000378:metabolism*; D017434:Protein Structure, Tertiary; D011509:Proteoglycans / Q000378:metabolism
chemical_list: D000199:Actins; D000911:Antibodies, Monoclonal; D005353:Fibronectins; D009842:Oligopeptides; D010446:Peptide Fragments; D011509:Proteoglycans; D005780:Gelatin; D006493:Heparin; D002809:Chondroitin Sulfates; C046617:arginyl-glycyl-aspartyl-serine